Is There a Link Between Yeast and Psoriasis?
Yes, there is a clinically significant association between yeast (Candida) and psoriasis, with Candida colonization occurring more frequently in psoriatic patients and potentially exacerbating disease, particularly in intertriginous areas and difficult-to-treat locations.
The Evidence for Association
Multiple lines of evidence demonstrate a clear link between Candida and psoriasis:
Prevalence Data: Candida colonization rates are substantially elevated in psoriatic patients compared to healthy controls. Meta-analysis shows psoriatic patients have 3.44 times higher odds of oral Candida colonization (95% CI: 2.38-5.00) and 5.31 times higher odds of developing oral Candida lesions (95% CI: 1.04-27.23) 1. In clinical studies, oral Candida colonization ranges from 20-47% in psoriatic patients versus 0-2.8% in controls 2, 3, 4.
Disease Severity Correlation: The presence and burden of Candida correlates directly with psoriasis severity. Studies demonstrate a statistically significant association (P = 0.033) between clinical severity of psoriasis and presence of Candida 3. Colony counts correlate positively with disease severity (P < 0.001) 4.
Anatomical Considerations: The American Academy of Dermatology guidelines specifically note that secondary candidiasis must be considered when psoriasis presents in body folds where moisture is trapped 5. The guidelines emphasize this can complicate both diagnosis and treatment, though they note that absence of satellite pustules makes secondary candidal infection less likely.
Clinical Implications and Mechanisms
Immunologic Pathway: Recent research reveals shared inflammatory pathways through the IL-17/IL-23 axis. Fungi including Candida may trigger or exacerbate psoriasis through activation of this pathway 2, 6. This explains why IL-17 inhibitor therapies (secukinumab, ixekizumab, brodalumab) are associated with increased mucocutaneous Candida infections, with incidence rates of 1.2-2.0 per 100 patient-years 7, 8.
Bidirectional Relationship: The relationship appears bidirectional - psoriasis may predispose to Candida colonization through immune dysregulation, while Candida may trigger or worsen psoriasis through inflammatory mechanisms 2, 4.
Practical Clinical Approach
When to Suspect Candida:
- Inverse psoriasis in intertriginous areas (breasts, groin, axillae, intergluteal clefts)
- Erythematous, minimally indurated, nonscaling plaques in moist areas
- Presence of satellite papules or pustules (though absence doesn't exclude infection) 5
- Difficult-to-treat psoriasis in genital, oral, or nail areas 2
- Patients on immunosuppressive therapies or IL-17 inhibitors 7, 1
Diagnostic Confirmation: Cytopathological examination should be performed routinely in psoriatic patients, particularly those with moderate-to-severe disease or difficult-to-treat areas 3. Clinical examination alone is insufficient - laboratory confirmation through oral/skin scrapings is recommended 3, 4.
Treatment Considerations: When Candida is confirmed in psoriatic patients, standard antifungal therapy should be initiated. Studies show that treating the underlying psoriasis (particularly with apremilast) can reduce fungal burden - 83% of patients colonized with single Candida species achieved full recovery, while those with multiple species showed significant reduction in fungal load 2.
Important Caveats
Treatment-Related Risk: Patients receiving IL-17 inhibitors face increased Candida infection risk, though most infections are mild-to-moderate, occur once, resolve spontaneously, and rarely require treatment discontinuation 8. The majority (63.5-80.8%) require no antifungal medication or only topical therapy 8.
Screening Recommendations: While not universally mandated, cytopathological screening for oral Candida should be considered part of routine workup for psoriatic patients, especially those with moderate-to-severe disease 3. This is particularly important before initiating IL-17 inhibitor therapy 7.
Differential Diagnosis: Don't assume all intertriginous lesions in psoriatic patients are purely psoriatic - consider and test for secondary Candida infection, as this changes management 5.